DrugPatentWatch Database Preview
ONDANSETRON HYDROCHLORIDE Drug Profile
Which patents cover Ondansetron Hydrochloride, and what generic alternatives are available?
Ondansetron Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Lannett Co Inc, Luitpold, Mylan Labs Ltd, Pliva Hrvatska Doo, Qilu Pharm Co Ltd, Sagent Pharms, Sandoz Inc, Sun Pharm Inds (in), Teva, West-ward Pharms Int, Wockhardt, Amneal Pharms, Apotex, Aurobindo Pharma, Taro, Casi Pharms Inc, Chartwell Molecules, Dr Reddys Labs Ltd, Glenmark Generics, Hikma Intl Pharms, Ipca Labs Ltd, Mylan, Natco Pharma Ltd, Emcure Pharms Ltd, Sun Pharm Inds Ltd, and Taro Pharms Ireland. and is included in sixty-eight NDAs.
The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Seventy-nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Summary for ONDANSETRON HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 35 |
| NDAs: | 68 |
| Suppliers / Packagers: | 76 |
| Bulk Api Vendors: | 59 |
| Clinical Trials: | 422 |
| Patent Applications: | 992 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ONDANSETRON HYDROCHLORIDE |
| DailyMed Link: | ONDANSETRON HYDROCHLORIDE at DailyMed |
Pharmacology for ONDANSETRON HYDROCHLORIDE
| Drug Class | Serotonin-3 Receptor Antagonist |
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
Synonyms for ONDANSETRON HYDROCHLORIDE
| 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one hydrochloride |
| 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride |
| 103639-04-9 |
| 110204-46-1 |
| 110707-92-1 |
| 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride |
| 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride |
| 9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-2,3-DIHYDRO-1H-CARBAZOL-4(9H)-ONE HYDROCHLORIDE |
| 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride |
| 9-METHYL-3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-1,2,3,9-TETRAHYDRO-CARBAZOL-4-ONE HYDROCHLORIDE |
| 9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride |
| 9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4h-carbazol-4-onhydrochlorid |
| 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one hydrochloride |
| 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride |
| 99614-01-4 |
| 99614-02-5 (Parent) |
| A800774 |
| AB0016622 |
| AB07046 |
| AB2000081 |
| AC-12464 |
| AC1L2A5S |
| AC1Q3ERO |
| AK321977 |
| AKOS015889292 |
| API0003688 |
| BB_SC-1124 |
| BC204680 |
| BG0279 |
| C18H19N3O.HCl |
| CCG-100852 |
| CCG-221058 |
| CHEMBL1201111 |
| CPD000469179 |
| CS-1715 |
| CTK8F0270 |
| Emeset |
| Emetron |
| GR 38032F HYDROCHLORIDE |
| GS-3597 |
| H39O049 |
| HMS1571C18 |
| HY-B0002 |
| I01-1935 |
| I06-0131 |
| I06-131 |
| LS-51879 |
| MFCD00833882 |
| MKBLHFILKIKSQM-UHFFFAOYSA-N |
| MLS001304076 |
| MLS001401397 |
| MLS002222312 |
| MolPort-003-983-448 |
| NC00102 |
| NSC 665799 |
| NSC-665799 |
| NSC665799 |
| O0407 |
| O739 |
| Ondansetron (Hydrochloride) |
| ONDANSETRON HCl |
| Ondansetron hydrochloride (Zofran) |
| Ondansetron hydrochloride and dextrose in plastic container |
| Ondansetron hydrochloride and sodium chloride in plastic container |
| Ondansetron hydrochloride preservative free |
| Ondansetron hydrochloride, 98% |
| Ondemet |
| Ondemet;Emeset;Emetron;Zofran |
| OSETRON HYDROCHLORIDE |
| PubChem17490 |
| Q-201515 |
| REGID_for_CID_68647 |
| RT-014862 |
| s1390 |
| SAM001246631 |
| SCHEMBL41455 |
| SMR000469179 |
| SN 307 |
| SN 307 HYDROCHLORIDE |
| TL8000158 |
| VU0424014-2 |
| Zofran |
| Zofran and dextrose in plastic container |
| ZOFRAN PRESERVATIVE FREE |
US Patents and Regulatory Information for ONDANSETRON HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 076252-003 | Jun 25, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Casi Pharms Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077517-003 | Jun 25, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Taro | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | SOLUTION;ORAL | 077009-001 | Nov 30, 2007 | AA | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Mylan Labs Ltd | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 078244-001 | Apr 23, 2008 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
